[1] |
SUN Xian, LIU Rui, WU Ting, LIU Donghua. Immune response to Talaromyces marneffei melanin in BALB/c mice[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 660
-662
. |
[2] |
TIAN Jun, ZHU Longfei, LI Qiang, LIShuli, LIU Bangmin, LI Chunying, GAO Tianwen.. Assessment of the efficacy and side effects of systemic corticosteroid in the treatment of patients with progressive vitiligo[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(7): 403
-406
. |
[3] |
ZHUANG Le, MA Weiyuan.. Expression of miR-203 and its downstream targets p63 and survivin in the keloid lesions[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(7): 413
-415
. |
[4] |
WANG Zhengxiang, ZHANG Guoqiang, GAO Shunqiang, LIU Siyuan.. The effect of c-kit on A375 cell proliferation and apoptosis[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(7): 416
-420
. |
[5] |
ZHANG Nanxue, WANG Shuqing, JIANG Tao, YANG Linlin, MA Ying. Neonatal varicella: a case report[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 688
-689
. |
[6] |
YANG Hedan, JIANG Juan. Update of mechanism and treatment of herpes simplex virus infection[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 694
-697
. |
[7] |
SHEN Jiyang, LI Wei, MAN Xiaoyong, ZHENG Min. Update of PTTG1 and its binding factor PBF in dermatology[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(7): 431
-435
. |
[8] |
SUN Xianqi, LI Yuzhen.. Update of Muir-Torre syndrome[J]. China Journal of Leprosy and Skin Diseases, 2017, 33(8): 510
-512
. |
[9] |
LU Haihong .. Assessment of the efficacy of prednisone combined with thalidomide in the treatment of severe type-2 leprosy reactions [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(2): 77
-79
. |
[10] |
HOU Xiaoxiao, CAO Ke, HU Tingting, PAN Zhanyan, Christos C. Zouboulis, JU Qiang.. Effect of Bap and PGN on the expression of inflammatory cytokines in human SZ95 sebocytes in vitro[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(2): 83
-86
. |
|